Ralph Morales, DO
Sports Medicine · Brunswick, GANPI 1790773703
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (38.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Arthrex at 40.3% of the total. Reporting peaked in 2020 at $1,295 and has fallen 87.7% since, to $160 in 2024.
Across 38 payments — averaging $81.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1K
- Catalyst Orthoscience$893
- Zimmer Biomet$287
- Vericel Corporation$273
- Stryker$76
- Johnson & Johnson$63
- plus $263 from 11 others
What the payments were for
- Consulting fees$74324%
- Food & beverage$1,15837%
- Education$1,20439%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 4 | $1,250 |
| Catalyst Orthoscience | 2 | $893 |
| Zimmer Biomet | 5 | $287 |
| Vericel Corporation | 8 | $273 |
| Stryker | 1 | $76 |
| Johnson & Johnson | 4 | $63 |
| Si-bone, Inc. | 3 | $54 |
| Fidia Pharma USA Inc. | 2 | $39 |
| Sonex Health, Inc. | 1 | $32 |
| Pacira Therapeutics, Inc. | 1 | $25 |
| Team 1, LLC | 1 | $22 |
| Acacia Pharma Inc | 1 | $18 |
| Boston Scientific | 1 | $17 |
| Medtronic | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Heraeus Medical, LLC. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Catalyst Total CSR$893
- MACI$158
- Robotics$123
How this compares
$3,105 in reported general payments places this provider in the 65th percentile of 168 sports medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 22 | $250 |
| Meloxicam | 127 | $249 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $242 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $92 |
| Tramadol Hcl | 13 | $64 |
| Diazepam | 12 | $20 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Brunswick
- Gregory KelleyBrunswick$3K
- John XerogeanesAtlanta$4M
- Joseph BurnsAlpharetta$376K
- Sameh LabibBrookhaven$280K
- Spero KarasAtlanta$137K
- Xavier DuraldeAtlanta$77K
- Thomas MyersAtlanta$72K
- Robert O'ConnellCarrollton$69K
- Elan GolanSnellville$57K
- Taylor PolanderJesup$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.